Panome Bio: Funding, Investors & Team (Sep 2026)
Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports. Our Next-Generation Metabolomics platform is making major advancements in the metabolism field by going beyond pairwise comparisons and making complex experiments with large and complicated datasets possible. Cutting-edge technology and computational methods are used to extract only the biologically-relevant chemical compounds to give you a clearer view of phenotype. We provide a global and unbiased view of the metabolome through a suite of complementary LC/MS assays that captures the breadth of diverse metabolites in biological systems. We have the ability to complement your metabolomics data with proteomics to better understand pathways and metabolism through our partnership with Somalogic. Somalogic’s SomaScan® 7K Assay is a high-throughput proteomics assay that screens 7,000 proteins per sample simultaneously.
Panome Bio has raised $6.0M across 1 funding round on record, the most recent an undisclosed round of $6.0M announced in Nov 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Panome Bio Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Panome Bio Funding Rounds
Panome Bio Founders and Leadership Team
Contact details for the Panome Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Panome Bio Funding Compared to Other Biotechnology Startups
Panome Bio's latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Panome Bio in Biotechnology and St Louis
Companies Similar to Panome Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Panome Bio Funding FAQs
What does Panome Bio do?
Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports. Our Next-Generation Metabolomics platform is making major advancements in the metabolism field by going beyond pairwise comparisons and making complex experiments with large and complicated datasets possible. Cutting-edge technology and computational methods are used to extract only the biologically-relevant chemical compounds to give you a clearer view of phenotype. We provide a global and unbiased view of the metabolome through a suite of complementary LC/MS assays that captures the breadth of diverse metabolites in biological systems. We have the ability to complement your metabolomics data with proteomics to better understand pathways and metabolism through our partnership with Somalogic. Somalogic’s SomaScan® 7K Assay is a high-throughput proteomics assay that screens 7,000 proteins per sample simultaneously.
How much funding has Panome Bio raised?
Panome Bio has raised $6.0M across 1 round on record. The most recent is an undisclosed round of $6.0M announced in Nov 2024.
When did Panome Bio last raise funding?
Panome Bio's most recent funding round on record is an undisclosed round of $6.0M, announced in Nov 2024.
Who founded Panome Bio?
FundedIQ lists Gary J Patti (Founder) at Panome Bio.
Where is Panome Bio headquartered?
Panome Bio is based in St Louis, Missouri, United States.
How many employees does Panome Bio have?
Panome Bio is in the 1-10 employee band.
How does Panome Bio's funding compare to other Biotechnology startups?
Panome Bio's latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Panome Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Panome Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.